BEXXAR®

(Tositumomab)

Documentation

Patented
Approved 2003
FDA Letter
FDA Label
Full Sequence

Brief Summary

Function Type: Radiation
Target: CD20
Indication Category: Cancer

Approved Indications

Detailed Summary

Side Effects

References

Wikipedia
Drugs.com
FDA